Søgning
Søgning på udtrykket 'ecdc' giver 26 resultater
Nyt fra tidsskrifterne [6] Aktuelle smitsomme sygdomme [+20]
Nyt fra tidsskrifterne [6]
Lancet
1.03.2024
Experts say new head Pamela Rendi-Wagner should focus on pandemic preparedness and other infectious diseases. Udani Samarasekera reports.
Antimicrobial Agents And Chemotherapy
19.12.2024
Antimicrobial Agents and Chemotherapy, Ahead of Print.
International Journal of Infectious Diseases
25.09.2024
…months of 2024, more than 8000 confirmed human cases of Oropouche virus disease (OVD) were reported in endemic regions in addition to Cuba, a country not previously reporting cases[1]. In parallel to the increase of cases in endemic regions, the European Centre for Disease Prevention and Control (ECDC) recently reported the first imported cases of OVD into Europe with 19 cases identified in Spain, Italy, and Germany related to recent travel to Cuba and Brazil, both areas currently experiencing outbreaks[2].
BMC Infectious Diseases
26.06.2024
…. . . Methods. A total of 28 acute care hospitals in the Lombardy region, Northern Italy, participated in the third European Point Prevalence Survey (PPS-3) coordinated by ECDC for the surveillance of HAIs in acute care hospitals (Protocol 6.0). . . . Results. HAIs were detected in 1,259 (10.1%, 95% CI 9.6–10.7%) out of 12,412 enrolled pat…
PLoS One Infectious Diseases
21.03.2024
… HAI rates obtained through longitudinal and cross-sectional studies. Methods Results from two studies conducted simultaneously in four LTCFs in Italy were compared: a longitudinal study promoted by the European Centre for Disease Prevention and Control (ECDC, HALT4 longitudinal study, H4LS), and a PPS. Prevalence was estimated from the PPS and converted into incidence per year using an adapted version of the Rhame and Sudderth formula proposed by the ECDC. Differences between incidence rates calculated fr…
International Journal of Infectious Diseases
21.03.2024
Human monkeypox, a previously rare viral zoonosis, predominantly endemic to central and western Africa, emerged in May 2022 in non-endemic countries [1]. Initially confirmed in England [2], human autochthonous cases spread across 113 countries around the world, including 106 countries which had never previously reported monkeypox virus (MPXV) (www.cdc.gov/poxvirus/mpox/response/2022/world-map.html). Nearly 26,000 cases have been reported in Europe (monkeypoxreport.ecdc.europa.eu/).
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
ECDC COVID-19 updates
17.12.2024
This core protocol for ECDC studies of VE against hospitalisation with SARI laboratory-confirmed with SARS-CoV-2 or with influenza, version 4.0, represents an update to the main elements for a multi-country hospital-based study of COVID-19 vaccine effectiveness in patients hospitalised with SARI, initially published as version 1.0.
ECDC COVID-19 updates
10.12.2024
ECDC has launched an online platform, RespiCompass, which uses mathematical modelling to simulate respiratory disease dynamics under different scenarios.
Eurosurveillance latest updates
6.12.2024
.
Eurosurveillance latest updates
26.10.2024
.
Eurosurveillance latest updates
27.09.2024
.
ECDC Epidemiological Update
22.08.2024
This report provides an overview of the total number of cases of mpox (monkeypox) reported to ECDC and the WHO Regional Office for Europe through IHR/EWRS mechanisms .
ECDC COVID-19 updates
12.04.2024
In this episode we take a closer look at the data collection for respiratory viruses and why we should take this more seriously than just a cough or a sneeze.
ECDC COVID-19 updates
6.02.2024
This core protocol for ECDC studies of VE against hospitalisation with SARI laboratory-confirmed with SARS-CoV-2 or with influenza, version 3.0, represents an update to the main elements for a multi-country hospital-based study of COVID-19 vaccine effectiveness in patients hospitalised with SARI, initially published as version 1.0 [5], updated to version 2.0 [6].
ECDC Communicable Disease Threats Report
3.01.2025
This issue of the CDTR covers the period 28 December 2024 – 3 January 2025 and includes updates on respiratory viruses, avian influenza A(H5N1), acute respiratory infections complicated by malaria, and mpox.
ECDC Communicable Disease Threats Report
21.12.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14-20 December 2024 and includes updates on Cyclone Chido, Mpox due to monkeypox virus clade I and II, SARS-CoV-2 variant classification, Overview of respiratory virus epidemiology in the EU/EEA, Marburg virus disease and Avian influenza A(H5N1).
ECDC COVID-19 updates
20.12.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14-20 December 2024 and includes updates on Cyclone Chido, Mpox due to monkeypox virus clade I and II, SARS-CoV-2 variant classification, Overview of respiratory virus epidemiology in the EU/EEA, Marburg virus disease and Avian influenza A(H5N1).
ECDC Communicable Disease Threats Report
20.12.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 November - 6 December2024 and includes updates on increases in respiratory infections due to Mycoplasma pnemoniae in the EU/EEA, SARS-CoV-2 variant classification, Influenza A(H5N1), Avian influenza, Middle East respiratory syndrome, an unknown disease in the Democratic Republic of the Congo, mpox, suspected viral hemorrhagic fever in Sierra Leone, and overview of respiratory virus epidemiology in the EU/EEA.
ECDC Communicable Disease Threats Report
20.12.2024
This issue of the CDTR covers the period 16-22 November 2024 and includes updates on chikungunya, dengue, avian influenza, West Nile virus, mpox, severe floods in eastern Spain, identification of cVDPV2 in sewage samples, and an overview of respiratory virus epidemiology in the EU/EEA.
ECDC COVID-19 updates
19.12.2024
Almost all countries reporting data to ECDC are observing sharp increases in indicators of both influenza and respiratory syncytial virus (RSV) activity, with a visible impact in secondary care.
ECDC COVID-19 updates
19.12.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7-13 December 2024 and includes updates on measles, chikungunya, dengue, avian influenza, mpox, West Nile virus, circulating vaccine-derived poliovirus type 2, hepatitis A, suspected viral haemorrhagic fever in Sierra Leone, an unknown disease in the Democratic Republic of Congo, and an overview of respiratory virus epidemiology in the EU/EEA.
ECDC Epidemiological Update
19.12.2024
Almost all countries reporting data to ECDC are observing sharp increases in indicators of both influenza and respiratory syncytial virus (RSV) activity, with a visible impact in secondary care.
ECDC Communicable Disease Threats Report
14.12.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7-13 December 2024 and includes updates on measles, chikungunya, dengue, avian influenza, mpox, West Nile virus, circulating vaccine-derived poliovirus type 2, hepatitis A, suspected viral haemorrhagic fever in Sierra Leone, an unknown disease in the Democratic Republic of Congo, and an overview of respiratory virus epidemiology in the EU/EEA.
ECDC COVID-19 updates
14.12.2024
In EU/EEA countries, while SARS-CoV-2 activity remains low, both influenza and RSV activity are increasing. Vaccination campaigns have started in many EU/EEA countries. People who are eligible for vaccination, particularly those at higher risk of severe outcomes, are encouraged to get vaccinated.
ECDC COVID-19 updates
7.12.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 November - 6 December2024 and includes updates on increases in respiratory infections due to Mycoplasma pnemoniae in the EU/EEA, SARS-CoV-2 variant classification, Influenza A(H5N1), Avian influenza, Middle East respiratory syndrome, an unknown disease in the Democratic Republic of the Congo, mpox, suspected viral hemorrhagic fever in Sierra Leone, and overview of respiratory virus epidemiology in the EU/EEA.
ECDC COVID-19 updates
7.12.2024
In EU/EEA countries, respiratory syncytial virus (RSV) activity remains high. Influenza activity remains low but is slowly increasing. SARS-CoV-2 activity remains at low levels.